Lauxera Capital Partners
Investor profile
Venture capital
Lauxera Capital Partners has backed 5 European tech companies across 5 funding rounds between 2021 and 2026, joining rounds totalling €293M. Most active in Healthtech. Data as of Nov 2026.
Deals
5
distinct rounds
Companies
5
backed
Active span
2021–2026
6 yrs
Total round €
€293M
sum of rounds joined
Deals by year
distinct rounds / yearLauxera Capital Partners — deals by year — interactive chart.
Data table
| Lauxera Capital Partners — deals by year | |
|---|---|
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2026 | 1 |
Top sectors
by dealsLauxera Capital Partners — top sectors — interactive chart.
Data table
| Lauxera Capital Partners — top sectors | |
|---|---|
| Healthtech | 5 |
Stages
by dealsLauxera Capital Partners — stages — interactive chart.
Data table
| Lauxera Capital Partners — stages | |
|---|---|
| Series C | 3 |
| Other | 1 |
| Growth/Late | 1 |
Countries
by dealsLauxera Capital Partners — countries — interactive chart.
Data table
| Lauxera Capital Partners — countries | |
|---|---|
| France | 1 |
| Germany | 1 |
| Slovenia | 1 |
| Sweden | 1 |
| UK | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- Aescuvest1
- BIONIQ Capital1
- BlackRock Innovation Capital1
- Creadev1
- Cure Capital1
- J.P. Morgan1
- MTIP AG1
- Optum Ventures1
- Partech Ventures1
- PFM Health Sciences1
- Pictet Alternative Advisors1
- Plug & Play Growth Fund1
- Point72 Ventures1
- ProAssurance Corp1
- Relyens Group1
- Serena Capital1
- Surgical.AI1
- Symbiotic Capital1
- Vesalius Biocapital Partners1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Caresyntax | Germany | 1 | €164M |
| Natural Cycles | Sweden | 1 | €51M |
| Lifen | France | 1 | €50M |
| Organox | UK | 1 | €29M |
| GenePlanet | Slovenia | 1 | €0 |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Caresyntax | Series C | €164M | 2024-08 |
| Natural Cycles | Series C | €51M | 2024-05 |
| Lifen | Series C | €50M | 2021-11 |
| Organox | Other | €29M | 2023-07 |